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Editorial
Growth factors are soluble proteins that are 
capable of inducing cellular responses includ-
ing cell proliferation, survival, migration and 
differentiation. They function through binding 
to specific receptors on the surface of target cells 
and inducing signaling cascade in the cytoplasm. 
Depending on the proximity of the target cells, 
growth factors can be classified asparacrine 
(target cell is nearby), autocrine (target cell is 
the same cell that secreted the growth factor), 
juxtracrine (target cell must be in physical con-
tact with growth factor–receptor complex) or 
intracrine (growth factor–receptor complex is 
internalized). 
The ability of the growth factors to induce cel-
lular response primarily depends on target cell 
type, cell number, type and number of recep-
tors on target cells and finally the intracellular 
signal transduction cascades following growth 
factor binding to its receptor. In addition to these 
parameters, cellular response also depends on the 
ability of the growth factor to diffuse through the 
extracellular matrix (ECM). A growth factor can 
induce various cellular responses depending on 
the receptor and target cell type. The same recep-
tor can conduct distinct messages depending on 
the intracellular transduction pathways, which 
can differ from one cell type to another [1]. In the 
vicinity of cells, growth factors are often bound 
to proteoglycan molecules and this interaction 
modulates growth factor action and potency by 
regulating spatial presentation, diffusion prop-
erties, synthesis and degradation. For example, 
latent TGFb-binding protein is an ECM protein 
that stores TGFb, where TGFb can be released 
upon ECM remodeling by serum proteases [2].
Due to the critical modulatory role of growth 
factors in development and regeneration of tis-
sue, controlled delivery of growth factors to the 
defect site is crucial for regenerative medicine 
studies. Peptide nanofibers provide synthetic 
platforms to reconstruct both morpho logical 
characteristics and bioactive properties of cel-
lular microenvironments. Geometry of the 
high-aspect-ratio nanofibers formed by peptides 
allows dense presentation of bioactive epitopes 
to cells [3–5]. Due to these characteristics, pep-
tide nanofibers are widely used as growth fac-
tor carriers and delivery vehicles in regenerative 
medicine studies. 
Physical encapsulation of growth 
factors
Growth factors can be encapsulated in peptide 
nanostructures through noncovalent inter actions 
such as electrostatic interactions [6]. Release of 
encapsulated growth factors into surrounding 
tissue can be controlled through porosity, den-
sity and degradation rate of peptide nanofiber 
network. Synthetic systems inspired by natural 
ECM features can provide more controlled prop-
agation of growth factor signals to regulate cell 
decisions. Incorporation of growth factor-bind-
ing sites similar to ones in the ECM into syn-
thetic bio materials has attracted wide attention 
as a promising strategy to localize growth factor 
action on target cells or tissues. For example, 
heparin-mimetic systems have been used as deliv-
ery platforms to increase growth factor affinity 
to receptor for sustained release of growth fac-
tors and for extended half-life because heparin 
aids binding of growth factors to receptors more 
efficiently. Heparin-mimetic peptide nanofiber 
system was designed to mimic heparan sulfate, 
and bind to VEGF [7]. When endothelial cells 
were cultured on the heparin-mimetic peptide 
nanofibers, angiogenesis was induced in vitro 
without addition of exogenous growth factors 
and fast neo-vascularization was observed in rat 
cornea. These peptide nanofibers also showed 
specific binding affinity to other heparin-binding 
growth factors such as HGF and FGF-2 [8]. 
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In addition, both heparin-mimetic and laminin-
mimetic peptide nanostructures were used to 
induce neural differentiation through binding 
to NGF inducing neurogenesis. This system 
was shown to be effective in neural differen-
tiation even in the presence of axonal growth 
inhibitor chondroitin sulfate proteoglycans [9]. 
Heparin-binding peptide amphiphiles (HBPA) 
were also inspired by growth factor and heparin 
interactions. Cardin-Weintraub heparin-binding 
peptide domain was used to functionalize pep-
tide nanofibers to specifically bind to heparan 
sulfate. In the presence of sulfated glycosami-
noglycans, these peptide nanofibers captured 
heparin-binding growth factors, demonstrated 
prolonged release of angiogenic growth factors, 
and promoted vascularization when injected 
into rat cornea [10]. Effect of HBPA molecules 
on angiogenesis was also tested in a membrane 
system that was formed by HBPA, heparin and 
hyaluronic acid. This system was shown to pro-
mote retention of angiogenic factors and increase 
angiogenesis in chicken chorioallantoic mem-
brane assay [11]. Heparin-binding domain was 
also exploited in a RADA16 system by coupling 
the heparin-binding domain, LRKKLGKA, 
to the C terminus of RADA16 self-assembling 
peptide molecules [12–13].  
Growth factor tethering systems
Immobilization of growth factors by covalent 
binding to delivery material provides extended 
bioavailability, slower degradation, less inter-
nalization by cells, and spatial control of 
growth factor. However, covalent binding of 
growth factors to self-assembling peptides is 
not favored since growth factor binding may 
impede with self-assembly process. Previously, 
avidin-bound peptide amphiphile molecules 
were demonstrated for potential protein–
ligand binding [14]. In addition, researchers 
conjugated biotin molecules at the C-termini 
of peptide molecules, where biotinylated IGF-1 
was complexed with streptavidin and coupled 
to biotinylated self-assembling peptides. This 
sandwich strategy did not hinder self-assembly 
process and allow prolonged IGF-1 delivery and 
activity [15].
Stimuli-responsive approaches
Stimuli-responsive materials are based on rapid 
transition of material upon stimulus such as 
pH or temperature change, or drug or enzyme 
concentration. Growth factor delivery requires 
precise adjustment of the release rate because 
differentiation should be induced in a timely 
manner. For example, timing VEGF release 
to initiate blood vessel formation and PDGF 
to stabilize already formed vessels is critical in 
angiogenesis. Otherwise an initial bolus delivery 
of PDGF may result in destabilization of ves-
sels followed by regression. Protease-dependent 
release systems release growth factors from 
delivery systems as material is degraded upon 
cleavage by proteases [16]. MMP enzymes are 
ECM-remodeling enzymes found in ECM in a 
tissue-specific manner. Peptides including cleav-
age sites for specific MMPs can be degraded by 
cell-secreted MMPs. In one study, peptide nano-
fibers functionalized with MMP-13 cleavage 
site showed sequence specific degradation when 
hydrogel was implanted into tissue [17]. Incorpo-
ration of MMP-binding site into peptide nano-
fibers provide tissue- and cell-dependent degra-
dation and in turn controlled bioavailability of 
growth factors. In another approach, assembly 
and disassembly processes of self-assembling 
peptides were controlled through incorporation 
of phosphorylation sites recognized by PKA. 
When peptide nanofibers were treated with 
PKA, they were phosphorylated, which resulted 
in dis assembly of peptide nanostructures and 
release of encapsulated bioactive reagents [18].
Growth factor mimicking strategies
Since growth factors have potency to induce 
several different cellular pathways in different tis-
sues, mode of growth factor delivery must target 
the specific cell population and minimize trans-
mission of signal to other cells or tissue. Delivery 
systems must induce cells with the accurate con-
centration of growth factors at the precise time 
frame to prevent undesired cellular decisions. In 
general, growth factors loaded in delivery sys-
tems are used at high concentrations to achieve 
sustained and slow-release of growth factors to 
target tissue for longer durations. These delivery 
strategies rely on use of recombinant exogenous 
growth factors, which may cause immunogenic 
responses and limit the clinical applicability. 
Growth factor-mimetic or -capturing systems 
have been used to eliminate these problems. 
Self-assembled peptide nanofibers presenting a 
VEGF-mimicking peptide sequence efficiently 
“Delivery systems must induce cells  
with the accurate concentration of growth 
factors at the precise time frame  
to prevent undesired  
cellular decisions.”
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induced tissue recovery in a hind-limb ischemia 
model of cardiovascular disease [19]. As discussed 
above, heparin mimetic strategies were also used 
as endogenously-released growth factor captur-
ing systems [7]. In addition, researchers designed 
peptide molecules that display TGFb-binding 
epitopes to sequester endogenously released 
TGFb growth factor. TGFb-binding PA sig-
nificantly enhanced recovery of microfracture-
treated cartilage defects without the addition of 
exogenous growth factors when implanted with 
mesenchymal stem cells [20].
Conclusions
During development and regeneration of tis-
sues, ECM modulates cellular functions through 
modulating concentration, transmission and 
localization of bioactive molecules including 
growth factors. In this sense, growth factor 
delivery systems inspired by native ECM should 
enhance growth factor potency and action by 
regulating localization, presentation and con-
centration of growth factors. Self-assembling 
peptides can be modified at single amino acid 
level to incorporate bioactive signals to bet-
ter mimic ECM-counterparts. Up-to-date, 
controlled and slow release of growth factors 
from self-assembled peptide constructs was 
achieved using noncovalent interactions and 
3D porous environment and it is possible to 
tune growth factor release by including glycos-
aminoglycans or glycosaminoglycans-mimetic 
molecules. However, application of these growth 
factor delivery systems in clinical cases will be 
limited, since they rely on exogenous recom-
binant growth factors. This challenge may be 
bypassed by using bioactive epitopes that cap-
ture and present endogenous growth factors or 
by using growth factor-mimics. Several stud-
ies showed that engineered peptide nanofibers 
enhanced cell differentiation and survival with-
out exogenous growth factor use by capturing 
endogenous growth factors or by mimicking 
growth factor itself. Regulating the localization 
of growth factor in target tissue and concentra-
tion in therapeutic range and eliminating adverse 
side-responses are some of the long-term goals 
of growth factor delivery strategies. Therefore, 
further improvements can be obtained through 
dynamic stimuli-responsive scaffolds that 
efficiently promote desired cellular induction.
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